Maaweya Awadalla

King Fahd Medical City — Saudi Arabia

Medicine · Health Sciences

7h-index200citations40works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(9), COVID-19 Clinical Research Studies(5), Computational Drug Discovery Methods(5), Respiratory viral infections research(5), Cervical Cancer and HPV Research(4)

Publications40 total

Comparative evaluation of Cox regression and machine learning approaches for survival prediction in stage IV lung cancer
Discover Computing·2026Open Access
Resistance, Virulence, and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infections in Saudi Arabia
Microorganisms·2026Open Access
In silico evaluation of the anti Helicobacter pylori activity of selected bioactive compounds from Aloe vera
Scientific Reports·2025Open Access
In-silico design and evaluation of quinoline-dione derivatives as Mycobacterium tuberculosis DprE1 inhibitors
Discover Molecules·2025· 3 citedOpen Access
Transcriptomic profile of the immune genes, oncogenes, and tumor suppressor genes in HPV associated Cervical Intraepithelial Neoplasia 3 (CIN 3) and Cervical Squamous Cell Carcinoma (CSCC): Comparable expressions indicative of invasive potential
Tumour Virus Research·2025Open Access
Crosstalk Between Immunity and Oncogenes Within the Tumor Microenvironment of HPV-Associated Cervical Squamous Cell Carcinoma
OncoTargets and Therapy·2025Open Access
Identification of natural product inhibitors as potential drug candidates for treating Alzheimer's disease: molecular docking, molecular dynamics simulations, MM/GBSA and pharmacokinetics
Network Modeling Analysis in Health Informatics and Bioinformatics·2025
Exploring the interplay between EBV and autophagy-related gene expression patterns in nasopharyngeal carcinoma
Frontiers in Oncology·2025· 1 citedOpen Access
Investigating the Interaction Mechanisms of Clostridium difficile Toxins with Host GTPases: A Bioinformatic Approach
2025Open Access
A goat experimental epistaxis model: Hemostatic effect of stop nosebleeds device
PLoS ONE·2025Open Access
In silico design of 3-methyl-3H-naphtho[1,2,3-de]quinoline-2,7-dione inhibitors against tuberculosis via docking and dynamics simulation techniques and pharmacokinetic evaluation
ASPET Discovery·2025Open Access
Design of a peptide-based vaccine against human respiratory syncytial virus using a reverse vaccinology approach: evaluation of immunogenicity, antigenicity, allergenicity, and toxicity
Frontiers in Immunology·2025· 8 citedOpen Access
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development
Frontiers in Immunology·2025· 1 citedOpen Access
Profiling the Tumor Immune Microenvironment of HPV-Associated Base of Tongue Squamous Cell Carcinoma
OncoTargets and Therapy·2025· 3 citedOpen Access
Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination
Frontiers in Immunology·2025· 6 citedOpen Access
A 10 Year Long‐Lived Cellular and Humoral MERS‐CoV Immunity Cross‐Recognizing the Wild‐Type and Variants of SARS‐CoV‐2: A Potential One‐Way MERS‐CoV Cross‐Protection Toward a Pan‐Coronavirus Vaccine
Journal of Medical Virology·2025· 3 citedOpen Access
Relationships Between Polymorphisms in HLA-G 3’UTR Region and COVID-19 Disease Severity
Biochemical Genetics·2024· 1 cited
Predictors of Human Papillomavirus (HPV) Vaccine Acceptability Among Physicians, Their Knowledge on Cervical Cancer, and Factors Influencing Their Decision to Recommend It
Journal of Multidisciplinary Healthcare·2024· 5 citedOpen Access
Factors influencing human papillomavirus vaccine uptake among parents and teachers of schoolgirls in Saudi Arabia: a cross-sectional study
Frontiers in Public Health·2024· 9 citedOpen Access
MERS-CoV Infection and Its Impact on the Expression of TSLP Cytokine and IgG Antibodies: An In Vivo and In Vitro Study
Infection and Drug Resistance·2024Open Access
page 1 of 2Next →

Frequent Co-authors

Bandar Alosaimi(26), Mohnad Abdalla(10), Wael Alturaiki(10), Reham M. Alahmadi(10), Samia T. Al‐Shouli(7), Haitham Alkadi(5), Wafa Ali Eltayb(5), Abdullah E. Al-Anazi(4), Huda M. Alshanbari(4), Halah Z. AlRawi(4), Amr Ahmed El‐Arabey(3), Taghreed N. Almanaa(3), Ayman Mubarak(3), Fawziya Barnawi(3), Muaawia A. Hamza(3), Asif Naeem(3), Ahmad S. AlYami(3), Heba W. Alhamdi(2), Saad Alamri(2), Mona Awad Alanazi(2)